Education
About Us
Working with TipRanks
Follow Us
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
Kiniksa Pharmaceuticals (KNSA) Ownership Overview
7.80% Insiders
19.57% Mutual Funds
43.10% Other Institutional Investors
14.68% ETFs
14.85% Public Companies and Individual Investors
The ownership structure of Kiniksa Pharmaceuticals (KNSA) stock is a mix of institutional, retail, and individual investors. Approximately 77.35% of the company’s stock is owned by Institutional Investors, 7.80% is owned by Insiders, and 14.85% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jun 11, 2025 | xxxxxxxxxxxxx | $833001 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $3203814 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $13576484 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $24480928 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,047,174 | Institution | 7.20% | 79,988,318 | |
| 2,818,323 | Institution | 6.66% | 73,980,979 | |
| 2,760,099 | Insider | 6.52% | 72,452,599 | |
| 2,647,757 | Institution | 6.25% | 69,503,621 | |
| 1,521,287 | Institution | 3.59% | 39,933,784 | |
| 1,102,248 | Institution | 2.60% | 28,934,010 | |
| 1,086,395 | Institution | 2.57% | 28,517,869 | |
| 800,935 | Institution | 1.89% | 21,024,544 | |
| 756,045 | Institution | 1.79% | 19,846,181 | |
| 715,204 | Institution | 1.69% | 18,774,105 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,647,757 | Institution | 6.25% | 69,503,621 | |
| 800,935 | Institution | 1.89% | 21,024,544 | |
| 756,045 | Institution | 1.79% | 19,846,181 | |
| 715,204 | Institution | 1.69% | 18,774,105 | |
| 408,065 | Institution | 0.96% | 10,711,706 | |
| 384,602 | Institution | 0.91% | 10,095,803 | |
| 377,652 | Institution | 0.89% | 9,913,365 | |
| 215,715 | Institution | 0.51% | 5,662,519 | |
| 159,650 | Institution | 0.38% | 4,190,813 | |
| 118,155 | Institution | 0.28% | 3,101,569 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,218,354 | Institution | 2.88% | 32,859,007 | |
| 991,650 | Institution | 2.34% | 26,030,813 | |
| 953,230 | Institution | 2.25% | 18,854,889 | |
| 527,992 | Institution | 1.25% | 14,239,944 | |
| 338,482 | Institution | 0.80% | 8,885,153 | |
| 191,773 | Institution | 0.45% | 5,172,118 | |
| 167,934 | Institution | 0.40% | 4,344,453 | |
| 167,934 | Institution | 0.40% | 4,344,453 | |
| 167,934 | Institution | 0.40% | 4,344,453 | |
| 140,266 | Institution | 0.33% | 3,628,681 |
FAQ
Who Owns Kiniksa Pharmaceuticals (KNSA)?
According to the latest TipRanks data, approximately 43.10% of the company's stock is held by institutional investors, 7.80% is held by insiders, and 14.85% is held by retail investors.
What percentage of Kiniksa Pharmaceuticals (KNSA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 43.10% of Kiniksa Pharmaceuticals (KNSA) stock is held by institutional investors.
What percentage of Kiniksa Pharmaceuticals (KNSA) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.85% of Kiniksa Pharmaceuticals (KNSA) stock is held by retail investors.
Who owns the most shares of Kiniksa Pharmaceuticals (KNSA)?
Vanguard owns the most shares of Kiniksa Pharmaceuticals (KNSA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.